Skip to main content
Midas Edge

ReShape Lifesciences Inc.

For the period ended Jun 30, 2025. Filed Aug 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 14, 2025

HIND$1.59+0.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

INDEX

​
PART I – FINANCIAL INFORMATION
​
Item 1.Condensed Consolidated Financial Statements (unaudited)3
​Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 20243
​Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2025 and 20244
​Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2025 and 20245
​Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2025 and 20246
​Condensed Consolidated Statements of Cash Flows for the three and six months ended June 30, 2025 and 20248
​Notes to Condensed Consolidated Financial Statements9
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations21
Item 3.Quantitative and Qualitative Disclosures About Market Risk28
Item 4.Controls and Procedures29
​
PART II – OTHER INFORMATION
​i
Item 1.Legal Proceedings30
Item 1A.Risk Factors31
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds31
Item 3.Defaults Upon Senior Securities31
Item 4.Mine Safety Disclosures31
Item 5.Other Information31
Item 6.Exhibits32
SIGNATURES33
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.